pholcodine has been researched along with Anaphylactic Reaction in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 6 (31.58) | 2.80 |
| Authors | Studies |
|---|---|
| Dahle, GO; De Pater, GH; Guttormsen, AB; Malvik, LB | 1 |
| Mahase, E | 1 |
| Turner, P; Warner, JO | 1 |
| Florvaag, E; Johansson, G | 1 |
| Anderson, J; Capon, M; Fernando, SL; Fulton, R; Green, S; Krupowicz, B; Li, J | 1 |
| Clarke, RC; Day, C; Goddard, CE; Middleditch, A; Platt, PR; Sadleir, PHM; Weightman, W | 1 |
| Anderson, J; Fernando, SL; Green, SL; Rose, MA; Yun, J | 1 |
| Dumancić, J; Marković, AS | 1 |
| Brusch, AM; Clarke, RC; Phillips, EJ; Platt, PR | 1 |
| de Pater, GH; Florvaag, E; Guttormsen, AB; Irgens, Å; Johansson, SG; Petersen, MN | 1 |
| Florvaag, E; Johansson, SG | 2 |
| Florvaag, E; Johansson, SG; Nopp, A; Oman, H | 1 |
| Dybendal, T; Florvaag, E; Garvey, LH; Gerth van Wijk, R; Guttormsen, AB; Halsey, J; Harper, NJ; Irgens, A; Johansson, SG; Mertes, PM; Metso, T; Oman, H; Poulsen, LK; Seneviratne, SL | 1 |
| de Pater, GH; Florvaag, E; Irgens, Å; Johansson, SG | 1 |
| Castells, MC; Dewachter, P; Hepner, DL; Mouton-Faivre, C | 1 |
| Degerbeck, F; Florvaag, E; Johansson, SG; Nopp, A; Oman, H; Tunelli, J | 1 |
| Degerbeck, F; Dybendal, T; Florvaag, E; Johansson, SG; Lundberg, M; Oman, H; Venemalm, L | 1 |
| Florvaag, E; Harboe, T; Johansson, SG; Oman, H | 1 |
3 review(s) available for pholcodine and Anaphylactic Reaction
| Article | Year |
|---|---|
[Correlation between pholcodine and perioperative anaphylaxis].
Topics: Anaphylaxis; Antitussive Agents; Codeine; Cross Reactions; Humans; Immunotherapy; Intraoperative Complications; Morpholines; Neuromuscular Blocking Agents; Postoperative Complications | 2012 |
Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis.
Topics: Allergens; Ammonium Compounds; Anaphylaxis; Codeine; Cross Reactions; Drug Hypersensitivity; Geography, Medical; Humans; Immunoglobulin E; Morpholines; Neuromuscular Blocking Agents; Norway; Perioperative Period | 2014 |
Anesthesia in the patient with multiple drug allergies: are all allergies the same?
Topics: Analgesics; Anaphylaxis; Anesthesia; Anesthetics; Anesthetics, Intravenous; Animals; Anti-Bacterial Agents; Codeine; Contrast Media; Cross Reactions; Drug Hypersensitivity; Egg Hypersensitivity; Fishes; Food Hypersensitivity; Glycine max; Humans; Hypersensitivity, Immediate; Iodine Compounds; Meat; Morpholines; Neuromuscular Blocking Agents; Peanut Hypersensitivity; Perioperative Period; Propofol; Risk Factors; Seafood | 2011 |
1 trial(s) available for pholcodine and Anaphylactic Reaction
| Article | Year |
|---|---|
Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents.
Topics: Adult; Allergens; Anaphylaxis; Antitussive Agents; Codeine; Female; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Male; Middle Aged; Morphine; Morpholines; Neuromuscular Blocking Agents; Skin Tests; Succinylcholine; Treatment Outcome | 2007 |
15 other study(ies) available for pholcodine and Anaphylactic Reaction
| Article | Year |
|---|---|
Gender-specific decline in perioperative allergic reactions in Norway after withdrawal of pholcodine.
Topics: Anaphylaxis; Codeine; Drug Hypersensitivity; Humans; Hypersensitivity; Morpholines; Norway | 2022 |
UK withdraws pholcodine-containing cough and cold medicines over anaphylaxis risk in surgery.
Topics: Anaphylaxis; Codeine; Cough; Humans; United Kingdom | 2023 |
Cough up, time's up: pholcodine and risk of anaphylaxis to general anaesthetics.
Topics: Anaphylaxis; Anesthetics, General; Codeine; Cough; Humans | 2023 |
Pholcodine, perioperative anaphylaxis, and the European Medicines Agency: finally the decision to remove pholcodine from the market in the European Union.
Topics: Anaphylaxis; European Union; Humans; Immunoglobulin E; Neuromuscular Blocking Agents | 2023 |
Measurement of pholcodine-specific IgE in addition to morphine-specific IgE improves investigation of neuromuscular blocking agent anaphylaxis.
Topics: Anaphylaxis; Codeine; Drug Hypersensitivity; Female; Humans; Immunoglobulin E; Male; Middle Aged; Morphine; Morpholines; Neuromuscular Blocking Agents | 2020 |
Relationship of perioperative anaphylaxis to neuromuscular blocking agents, obesity, and pholcodine consumption: a case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anaphylaxis; Bariatric Surgery; Case-Control Studies; Cefazolin; Codeine; Female; Humans; Incidence; Male; Middle Aged; Morpholines; Neuromuscular Blocking Agents; Obesity; Prospective Studies; Risk Factors; Rocuronium; Young Adult | 2021 |
Morphine and pholcodine-specific IgE have limited utility in the diagnosis of anaphylaxis to benzylisoquinolines.
Topics: Anaphylaxis; Benzylisoquinolines; Codeine; Drug Hypersensitivity; Female; Humans; Immunoglobulin E; Male; Morphine; Morpholines; Neuromuscular Blocking Agents; Skin Tests | 2018 |
Six years without pholcodine; Norwegians are significantly less IgE-sensitized and clinically more tolerant to neuromuscular blocking agents.
Topics: Adolescent; Adult; Aged; Anaphylaxis; Child; Codeine; Drug Hypersensitivity; Female; Follow-Up Studies; Humans; Immunoglobulin E; Male; Middle Aged; Morpholines; Neuromuscular Blocking Agents; Norway; Population Surveillance; Prevalence; Safety-Based Drug Withdrawals; Young Adult | 2017 |
IgE-mediated anaphylactic reactions to neuromuscular blocking agents: can they be prevented?
Topics: Analgesics; Anaphylaxis; Anesthesia; Antitussive Agents; Codeine; Drug Hypersensitivity; Drug Utilization; Humans; Immunoglobulin E; Morpholines; Neuromuscular Depolarizing Agents; Norway; Succinylcholine; Sweden | 2008 |
Pholcodine caused anaphylaxis in Sweden 30 years ago.
Topics: Analgesics; Anaphylaxis; Codeine; Drug Hypersensitivity; Humans; Immunoglobulin E; Morphine; Morpholines; Sweden | 2009 |
National pholcodine consumption and prevalence of IgE-sensitization: a multicentre study.
Topics: Anaphylaxis; Antitussive Agents; Codeine; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Morphine; Morpholines; Neuromuscular Agents; Phosphorylcholine; Prevalence; Quaternary Ammonium Compounds; Succinylcholine | 2010 |
IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market.
Topics: Anaphylaxis; Antitussive Agents; Codeine; Drug Hypersensitivity; Humans; Immunoglobulin E; Morpholines; Neuromuscular Blocking Agents; Norway; Safety-Based Drug Withdrawals | 2011 |
Anaphylaxis to atracurium - a non-QAI-dependent reaction?
Topics: Anaphylaxis; Antitussive Agents; Atracurium; Codeine; Humans; Morpholines; Neuromuscular Nondepolarizing Agents; Norway; Quaternary Ammonium Compounds; Sweden | 2012 |
Pholcodine in cough medicines and IgE-sensitization in the EU: an urgent task.
Topics: Anaphylaxis; Antitussive Agents; Codeine; Cough; European Union; Evidence-Based Medicine; Humans; Immunoglobulin E; Morpholines | 2012 |
Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively.
Topics: Algorithms; Analgesics, Opioid; Anaphylaxis; Antitussive Agents; Blood Donors; Codeine; Cross Reactions; Environmental Pollutants; Humans; Immunoglobulin E; Morphine; Morpholines; Neuromuscular Blocking Agents; Neuromuscular Depolarizing Agents; Norway; Succinylcholine; Sweden | 2005 |